RAFAEL HOLDINGS, INC. Proceeds from Notes Payable
RAFAEL HOLDINGS, INC. (RFL) reported Proceeds from Notes Payable of $10.00 billion for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. proceeds from notes payable for the quarter ending 2026-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. proceeds from notes payable for the quarter ending 2026-01-31 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. proceeds from notes payable for the quarter ending 2025-10-31 was $10.00B, a 99900.00% increase year-over-year.
- RAFAEL HOLDINGS, INC. proceeds from notes payable for the quarter ending 2025-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. proceeds from notes payable for fiscal 2025 was $10.00B, a 99900.00% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. proceeds from notes payable for fiscal 2024 was $10.00M.
- RAFAEL HOLDINGS, INC. proceeds from notes payable for fiscal 2021 was $15.00M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2026-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | $0.00 derived: sum of 2 quarters · filed 2026-06-11 | $10.00B 10-Q · filed 2026-06-11 | $10.00B derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | $10.00B 10-Q · filed 2026-03-16 | $10.00B derived: sum of 3 quarters · filed 2026-03-16 | $10.00B derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-10-31 | $10.00B 10-Q · filed 2025-12-12 | $10.00B derived: sum of 2 quarters · filed 2025-12-12 | $10.00B derived: sum of 3 quarters · filed 2025-12-12 | $19.99B derived: sum of 4 quarters · filed 2025-12-12 |
| 2025-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $9.99B derived: sum of 3 quarters · filed 2025-10-29 | $10.00B 10-K · filed 2025-10-29 |
| 2025-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | $9.99B derived: sum of 2 quarters · filed 2025-06-11 | $10.00B 10-Q · filed 2025-06-11 | $10.00B derived: sum of 4 quarters · filed 2025-06-11 |
| 2025-01-31 | $9.99B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | $10.00B 10-Q · filed 2025-03-14 | $10.00B derived: sum of 3 quarters · filed 2025-03-14 | |
| 2024-10-31 | $10.00M 10-Q · filed 2024-12-11 | $10.00M derived: sum of 2 quarters · filed 2024-12-20 | ||
| 2024-07-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $10.00M 10-K/A · filed 2024-12-20 | ||
| 2024-04-30 | $10.00M 10-Q · filed 2024-06-14 | |||
| 2021-07-31 | $15.00M 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |